News Archives - DrugGenius

News

Phathom Pharmaceuticals to Present at Upcoming Investor Conferences

FLORHAM PARK, N.J., May 28, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today…

View Post

News

UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference

SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced…

View Post

News

Geron Corporation Reports First Quarter 2020 Financial Results

MENLO PARK, Calif., May 28, 2020 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2020. The Company will host a…

View Post

News

Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities

– Lumos Pharma expects to initiate its Phase 2b LUM-201 trial in Pediatric Growth Hormone Deficiency (PGHD) prior to the end of 2020 – Additional non-dilutive funds expected from anticipated…

View Post

News

MatriSys Bioscience Inc. is pleased to announce that we have been selected as a CONNECT 2020 Cool Company

SAN DIEGO, May 28, 2020 (GLOBE NEWSWIRE) — MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics is pleased to announce that it was named a 2020 “Cool…

View Post

News

Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610

CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, will host…

View Post

News

Protect Pharmaceutical Commences Production of a New Kind of Green: Cannabis-Based “Green Wine”

Sevnica, Slovenia, May 28, 2020 (GLOBE NEWSWIRE) — Protect Pharmaceutical Corp. “OTC:(PRTT)” Protect Pharmaceutical Corp is excited to announce the commencement of its production of cannabis-based wine, also known as…

View Post

News

Anti-Inflammatory Drugs Market to Exhibit 9.3% CAGR by 2027; Owing to Rising Prevalence of Inflammatory Health Conditions: Fortune Business Insights™

Key Companies Covered in the Anti-Inflammatory Drugs Market Research Report are Novartis AG, AbbVie Inc., Biogen, Merck & Co., Inc., Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson…

View Post

News

Anti-fungal Drugs Market to Reach USD 13.17 Billion by 2027; Increasing Number of Infectious Skin Disorders to Aid Growth: Fortune Business Insights™

Key Companies Covered in the Anti-Fungal Drugs Market Research Report Are Merck & Co., Inc., Leadiant Biosciences, Inc., GlaxoSmithKline plc., Bayer AG, Astellas Pharma Inc., Pfizer Inc., McKesson Medical-Surgical Inc.,…

View Post

News

NSAIDs Market to Reach USD 24.35 Billion by 2027; Surging Research on Selective Cyclooxygenase-2 Inhibitors to Boost Growth: Fortune Business Insights™

Key Companies Covered in the non-steroidal anti-inflammatory drugs (NSAIDs) market Research Report Are Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Johnson & Johnson Services, Inc., Bayer AG, AstraZeneca, Zyla…

View Post